Search Results

Amgen news, articles and information:

a long time ago - Amgen news, articles and information:

Amgen admits to criminal behavior in off-label drug marketing scheme, receives minimal slap on wrist

Concepts related to Amgen

Today | Week | Month | YearSee All Top Headlines...Most Popular Stories

Recommended ResourcesCounterThink Cartoons are

free to view and download. They cover topics like health, environment and freedom.The Consumer Wellness Center is

a non-profit ...

Amgen admits to criminal behavior in off-label drug marketing scheme, receives minimal slap on wrist

March 07, 2013 - Amgen admits to criminal behavior in off-label drug marketing scheme, receives minimal slap on wrist

Thursday, March 07, 2013 by: Ethan A. Huff, staff writerTags: Amgen, off-label marketing, pharmaceutical profits

Breaking the law, paying civil fines just a cost of doing business for Big Pharma

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

More news on Amgen

Take Action: ...

Anemia drug found to cause fatal heart attacks and strokes

November 23, 2006 - Anemia drug found to cause fatal heart attacks and strokes

Thursday, November 23, 2006 by: Jerome DouglasTags: diabetes drugs, anemia, dangerous drugsThe report stated that anti-anemia doses in excess of the FDA's recommendations is common practice in the dialysis industry. It's known that the dialysis industry derives much of its revenue from administration of one of the anti-anemia drugs, Epogen -- which is made by Amgen, a large drug design and manufacturing ...

Big Pharma mergers and acquisitions destroy industry innovation and harm patients

February 19, 2021 - The wave of Big Pharma mergers and acquisitions across 10 years decreased the number of large international pharmaceutical companies from 60 to 10. They seemed like innocent business moves at first glance, but a closer look revealed a worrying trend for U.S. healthcare.

California Rep. Katie Porter's office published a 16-page report on Jan. 29 detailing the real reasons behind the mergers and acquisitions and recommending steps to minimize such movements in the future.

The ...

Statin-push quack Steven Nissen exposed for conflicts of interest, statin drug “prostitution” and science denialism

August 18, 2017 -

Nissen's opinion piece cites statistics published in the journal Annals of Internal Medicine showing that only 61 percent of patients administered a prescription for a statin drug continue taking it after three months. This he blames not on the laundry list of deadly side effects that are also widely reported in the scientific literature, but rather on anti-statin crusaders whom he laments are steering patients towards alternatives.

"[W]e are losing the battle for the ...

HHS buys $290 million worth of radiation sickness drugs in preparation for nuclear emergencies

October 07, 2022 -

This purchase was announced on Oct. 4 by the Administration for Strategic Preparedness and Response (ASPR), an agency within the HHS whose purpose is to prepare the nation for future disasters and public health emergencies.

In a statement, the ASPR said it purchased a drug called romiplostim, sold under the brand name Nplate by the California-based biopharmaceutical company Amgen. The purchase was made "as part of long-standing, ongoing efforts to be better ...

PHARMACEUTICAL FRAUD: Big Pharma’s corporate lawlessness cost Americans over $40B in 2019 alone

May 19, 2023 -

The report, released on May 16 by the American Economic Liberties Project (AELP) and the Initiative for Medicines, Access and Knowledge (I-MAK), zeroed in on the pharmaceutical giants' antitrust law violations. According to AELP and I-MAK, these are the main reasons why drug prices in America are skyrocketing at record-high levels compared to those of other rich nations.

"American families are paying far too much for prescription drugs, in large part due to rampant corporate ...

Genentech sets price gouging limit for Avastin cancer drug

October 13, 2006 - Genentech sets price gouging limit for Avastin cancer drug

Friday, October 13, 2006 by: Jessica FraserTags: Genentech, cancer drugs, drug profitsGenentech's announcement follows a decision by rival drug company Amgen two weeks ago to begin selling its colon cancer drug Vectibix at $4,000 per dose -- about 20 percent lower than the price of Bristol-Myers Sqibb's similar drug Erbitux. The price cap for Avastin comes after the U.S. Food and Drug Administration ...

Boycott these 60 companies that donate money to fund the systematic murder of unborn human babies

January 28, 2019 -

As the biggest single provider of abortions in America, Planned Parenthood performs more than 300,000 abortions each year, and their political arm works tirelessly to influence elections and implement liberal policies around the country. Undercover videos that came to light in recent years showed top execs from the group wining and dining agents who posed as buyers of baby body parts and cutting deals with them.

More than 25 percent of the $1.3 billion in revenue Planned ...

Here’s how AbbVie gamed the U.S. patent system to generate $114 billion in revenues from Humira drug

February 01, 2023 -

The world's best-selling anti-inflammatory drug, Humira is used by many to treat arthritis. In 2016, it was scheduled to see competition from a rival drug called Amjevita, made by Amgen, that regulators had approved – as well as from at least nine additional Humira competitors, including one from Pfizer.

AbbVie orchestrated the delay of these generic competitor releases for seven years by exploiting the United States patent system. What AbbVie did to accomplish ...

Bank of America analyst dubs Moderna stock price as ridiculous

August 19, 2021 -

Meacham wrote that Moderna's valuation went "from unreasonable to ridiculous." He pointed out that with the 11-year-old company's $195.56 billion value, it was worth more than other firms that have existed for a longer period. Meacham said Moderna exceeded the 40-year-old Amgen Inc. valued at $129.3 billion and the century-old Merck & Co. Inc. valued at $189.7 billion.

Moderna's stock prices shot up to about $484.87 after its two-dose mRNA vaccine received provisional ...

As society suffers, Big Pharma gets stronger and wealthier

February 15, 2021 -

Rep. Katie Porter (D-Calif.) published a damning report on Jan. 29 outlining the horrors of this deathcare system, and calling on Congress to enact "comprehensive, urgent reform" to fix it.

Entitled, "Killer Profits: How Big Pharma Takeovers Destroy Innovation and Harm Patients," Porter's report reveals how in just the past decade alone, the number of "large, international pharmaceutical companies (has) decreased six-fold, from 60 to 10."

The claim by company ...

Yet another corrupt judge BLOCKS Trump from trying to break Big Pharma’s drug price monopoly

July 24, 2019 -

According to reports, United States District Court Judge Amit P. Mehta of Washington, D.C., recently decided that drug companies like Amgen, Merck & Co., and Eli Lilly do not legally have to disclose drug prices to the Department of Health and Human Services (HHS), which means that patients will continue to have to pay sky-high prices for their medications.

While the Trump administration has been trying to hold drug companies accountable for their corrupt business ...

These Big Pharma and health care companies are funding the mass murder of black babies in America… learn the truth

December 26, 2018 -

As we reported last year, Planned Parenthood has played a pivotal role over at least the past century in the systematic extermination of black people through legalized abortion. As you may already know, Planned Parenthood has long perpetuated genocide against people with dark skin by calling its nefarious eugenics agenda "family planning," luring black people into getting abortions in the name of "reproductive rights."

With the spotlight now rightfully on the Women's ...

Big Pharma’s contradictory JUNK SCIENCE: Merck pulls “promising” Alzheimer’s drug from trials the same day Cleveland Clinic hails its success

March 07, 2018 -

The drug was going to be called verubecestat, but now it'll just be called a failure since a trial of the pharma pill on late-stage dementia patients showed that the drug "won't work," to quote the researchers involved with testing it. Merck was actually forced to shut down the trial, reports indicate, suggesting that it was likely harming late-stage dementia patients.

There were a number of other pharmaceutical companies besides just Merck that were betting on the drug's ...

naturalnews.com feature article archives

a long time ago -

Articles from NaturalNews In-House Writers:

Americans flocking to support Sen. Rand Paul for his tireless defense of the Constitution

Government email instructs department head to make sequestration as painful as possible

Coconut oil can stop dementia and Alzheimer's disease

USDA approves Monsanto alfalfa despite presence of infertility-causing pathogens

Amgen admits to criminal behavior in off-label drug marketing scheme, receives minimal slap on wrist

Chemical ...

FDA has granted “emergency-use authorization” to Eli Lilly’s coronavirus antibody treatment

November 12, 2020 -

The FDA extended the emergency approval to the experimental therapy known as “bamlanivimab.” It may be given to people 12 years old and older who have mild to moderate cases of the coronavirus and have not visited the emergency room or have been admitted to a hospital. Bamlanivimab is a one-time treatment that is administered through an IV.

In a statement, FDA Commissioner Stephen M. Hahn gave his support for the approval of bamlanivimab.Bamlanivimab is known ...

Big Pharma donations to lawmakers continue to roll in despite pandemic (or perhaps because of it)

September 10, 2020 -

An analysis by STAT found that the campaign contributions have amounted to around $11 million, which has come in the form of 4,500 checks from political action committees (PACs) that are connected to the firms in question.

This type of political giving is par for the course in an election year, with Big Pharma making a big series of modest donations to Congressional incumbents while avoiding making big donations to the presidential candidates. Their goal is to gain ...

Doctor blasts statin drug pusher Steven Nissen for using scare tactics to rake in more profits from toxic statin drugs

August 03, 2017 -

As to the second complaint, there is much hullabaloo over the use of statin drugs, which many in traditional medicine circles rely on and trust implicitly, while alternative medicine providers find to be unacceptably toxic. [To the latter, there is an argument to be made based on scientific evidence indicating statins cause harmful side effects including rapid aging, brain damage, and diabetes, among other problems.]

One of biggest defenders of statin use is Dr. Steve ...

Analysis: Big Pharma jacked up drug prices 1,186 times in 2022 alone

July 24, 2022 -

Patients For Affordable Drugs (PFAD) penned the July 20 report, which revealed that the U.S. drug industry raised the prices of various drugs a combined 1,186 times this year. P4AD seeks to curb the skyrocketing cost of prescription drugs.

Between June 24 and July 5, drug firms increased the prices of 133 products – with a median price increase of five percent. PFAD added that for the month of July alone, 64 drug companies increased the prices of their products.

Drug ...